2-溴-6-(1H-吡唑-1-基)吡啶 | 123640-41-5

• 物质功能分类: 医药中间体 - 杂环化合物 - 吡啶类化合物
• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 中文名称: 2-溴-6-(1H-吡唑-1-基)吡啶
• 英文名称: 2-bromo-6-(1H-pyrazol-1-yl)pyridine
• 英文别名: 2-bromo-6-(pyrazol-1-yl)pyridine；2-bromo-6-pyrazol-1-ylpyridine
• CAS: 123640-41-5
• 化学式: C₈H₆BrN₃
• 分子量: 224.06
• InChiKey: LPRJOZJWALGJGM-UHFFFAOYSA-N

物化性质

• 熔点：
  66-68
• 沸点：
  330.7±27.0 °C(Predicted)
• 密度：
  1.63±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.2
• 重原子数：
  12
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  30.7
• 氢给体数：
  0
• 氢受体数：
  2

安全信息

• 海关编码：
  2933990090
• 包装等级：
  III
• 危险类别：
  6.1
• 危险性防范说明：
  P261,P264,P270,P271,P280,P302+P352,P304+P340,P310,P330,P361,P403+P233,P405,P501
• 危险品运输编号：
  2811
• 危险性描述：
  H301,H311,H331
• 储存条件：
  室温

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 2-Bromo-6-(1H-pyrazol-1-yl)pyridine
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 2-Bromo-6-(1H-pyrazol-1-yl)pyridine
CAS number: 123640-41-5

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C8H6BrN3
Molecular weight: 224.1

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen bromide.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  2-溴-6-(1H-吡唑-1-基)吡啶 在 copper(I) oxide 、 氨 作用下， 以 乙二醇 为溶剂， 110.0 ℃ 、1.01 MPa 条件下， 反应 24.0h， 以81%的产率得到6-(1H-pyrazol-1-yl)pyridin-2-amine
  参考文献：
  名称：

  PHOSPHO-AMINO PINCER-TYPE LIGANDS AND CATALYTIC METAL COMPLEXES THEREOF

  摘要：

  本发明提供了磷酸氨基夹持型配体、其金属配合物以及包括这种金属配合物的催化方法。

  公开号：

  US20120323007A1
• 作为产物：
  描述：

  吡唑 、 2,6-二溴吡啶 在 potassium tert-butylate 作用下， 以 乙腈 为溶剂， 反应 48.0h， 以79.77%的产率得到2-溴-6-(1H-吡唑-1-基)吡啶
  参考文献：
  名称：

  混合价[2×2] Co 4网格配合物中氧化还原诱导的单分子磁性

  摘要：

  同价[2×2] Co 4网格络合物[Co II 4 L H 4 ]（BF 4）4（1）和[Co II 4 L Me 4 ]（BF 4）4（2），带有两个新的双（terdentate）吡唑基桥联的配体，HL H = 3,5-双（6-（1 H-吡唑-1-基）吡啶-2-基）吡唑和HL Me = 4-甲基-3,5-双（6-（合成并全面表征了1 H-吡唑-1-基）吡啶-2-基）吡唑。1和2的X射线晶体学分析钴（II）离子呈方形排列，每个金属离子处于扭曲的八面体{N 6 }配位，由正交配体链的两个齿状隔室产生。磁测量表明，金属离子的高自旋（S = 3/2）状态和适度的反铁磁相互作用，从而使整体抗磁S T = 0基态为1和2。通过电化学或化学方法两次氧化，生成二价二价[2×2] Co 4网格[Co II 2 Co III 2 L H 4 ]（BF 4）6（3）和[Co II 2 Co III 2 L Me

  DOI：

  10.1021/acs.inorgchem.6b00106

文献信息

• HETEROCYCLIC COMPOUND
  申请人：TAKEDA PHARMACEUTICAL COMPANY LIMITED

  公开号：US20160159773A1

  公开（公告）日：2016-06-09

  The present invention provides an agent for the prophylaxis or treatment of autoimmune diseases (e.g., psoriasis, rheumatoid arthritis, inflammatory bowel disease, Sjogren's syndrome, Behcet's disease, multiple sclerosis, systemic lupus erythematosus etc.) and the like, which has a superior Tyk2 inhibitory action. The present invention relates to a compound represented by the formula wherein each symbol is as defined in the specification, or a salt thereof.

  本发明提供了一种用于预防或治疗自身免疫性疾病（例如牛皮癣、类风湿关节炎、炎症性肠病、干燥综合征、贝赫切特病、多发性硬化症、系统性红斑狼疮等）等的药剂，其具有优越的Tyk2抑制作用。 本发明涉及一种由下式表示的化合物 其中每个符号如规范中定义的，或其盐。
• Heterocyclic Compound
  申请人：TAKEDA PHARMACEUTICAL COMPANY LIMITED

  公开号：US20180155333A1

  公开（公告）日：2018-06-07

  The present invention provide a compound having an orexin receptor antagonistic activity, which is expected to be useful as medicaments such as agents for the prophylaxis or treatment of sleep disorder, depression, anxiety disorder, panic disorder, schizophrenia, drug dependence, Alzheimer's disease and the like. The present invention relates to a compound represented by the formula (I): wherein each symbol is as defined in the specification, or a salt thereof.

  本发明提供了一种具有促醒素受体拮抗活性的化合物，预计可用作药物，如预防或治疗睡眠障碍、抑郁症、焦虑症、恐慌症、精神分裂症、药物依赖、阿尔茨海默病等的药剂。 本发明涉及由以下式（I）表示的化合物： 其中每个符号如规范中定义，或其盐。
• Metal-free site-selective C–N bond-forming reaction of polyhalogenated pyridines and pyrimidines
  作者：Lei Wang、Ning Liu、Bin Dai

  DOI：10.1039/c5ra18653f

  日期：——

  of the pyridine ring to generate monosubstituted halogenated pyridines with high selectivities. Different halogen atoms at various positions were produced by the pyridine ring that performed well under mild conditions. Halogenated pyrimidines underwent highly selective coupling at the chloride group with a wide range of amines having broad substrate applicability and moderate to good yields. The selectivity

  本文提出了一种多金属的方法，用于多位卤代吡啶和嘧啶的高位点选择性C–N键形成反应。当从吡啶环变为嘧啶环时，优选的偶联位点可从带有N-杂环的氟基团调节至氯基团。各种各样的卤代吡啶优先与吡啶环氟原子上的胺反应，生成具有高选择性的单取代卤代吡啶。吡啶环在不同位置产生了不同的卤素原子，这些吡啶环在温和的条件下表现良好。卤代嘧啶在氯化物基团上与多种胺进行高度选择性的偶联，这些胺具有广泛的底物适用性并且产率中等至良好。氮环的邻位。该反应容纳了广泛的卤代基团。因此，产生了大量的氯，溴，碘和氟吡啶，它们对于有机合成具有广泛的用途。
• Heterocyclic Compounds as Pesticides
  申请人：BRETSCHNEIDER Thomas

  公开号：US20110166143A1

  公开（公告）日：2011-07-07

  The present application relates to the use of heterocyclic compounds, some of which are known, for controlling animal pests including arthropods and in particular insects, furthermore to novel heterocyclic compounds and to processes for their preparation.

  本申请涉及使用杂环化合物来控制动物害虫，包括节肢动物，特别是昆虫，此外还涉及新型杂环化合物及其制备方法。
• Phosphine Ligand‐Free Ruthenium Complexes as Efficient Catalysts for the Synthesis of Quinolines and Pyridines by Acceptorless Dehydrogenative Coupling Reactions
  作者：Bin Guo、Tian‐Qi Yu、Hong‐Xi Li、Shi‐Qi Zhang、Pierre Braunstein、David J. Young、Hai‐Yan Li、Jian‐Ping Lang

  DOI：10.1002/cctc.201900435

  日期：2019.5.20

  corresponding ligand in EtOH. Five Ru(II) complexes [LRu(DMSO‐κS)Cl2] (2 a: L=L1; 2 b: L=L2; 2 c: L=L3; 2 d: L=L4; 2bMe: L=L2Me) were formed by reducing the corresponding Ru(III) complex in refluxing EtOH. The latter complexes could also be prepared directly by refluxing Ru(DMSO)4Cl2 with the corresponding ligand in EtOH. These Ru(III) and Ru(II) complexes, especially 1 b/2 b, exhibited high catalytic

  一系列游离膦-钌（III）/钌（II）NH的官能络合物Ñ Ñ Ñ钳配体表现出为仲醇的acceptorless脱氢偶联（ADC）具有优异的活性与2-氨基苄基或γ -氨基醇，以喹啉和吡啶。的Ru（III）配合物[LRuCl 3 ]（L = 6-（3-R 1，5-R 2 -1H-吡唑-1-基）-N-（吡啶-2-基）吡啶-2-胺; 1 a：R 1 = R 2 = H（L1）; 1 b：R 1 = R 2 = Me（L2）; 1 c：R 1 = H，R 2 = CF 3（L3）; 1 d：R 1＝ H，R 2＝ Ph（L4）；1b Me：通过回流获得L = 6-（3,5-二甲基-1H-吡唑-1-基）-N-甲基-N-（吡啶-2-基）吡啶-2-胺（L2 Me））的RuCl 3  ⋅XH 2 O运用在EtOH相应配体。五种Ru（II）络合物[LRu（DMSO-κS）Cl 2 ]（2 a：L = L1; 2